MiRNA-218 inhibits cell proliferation, migration and invasion by targeting Runt-related transcription factor 2 (Runx2) in human osteosarcoma cells
Related Experiment Video
Updated: Oct 8, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Qiang Guo1, Junan Ma2, Jing Wu3
1Department of Thoracic Surgery, Jinan Fifth People's Hospital, No. 24297, Jingshi Road, Huaiyin District, Jinan City, Shandong, 250022, China.
Purpose:
The deregulation of miRNA-218 has been found in a number of cancers. Using miRNA-218 as a target for Runt-related transcription factor 2 (Runx2), we sought to understand the role of miRNA-218 in osteosarcoma (OS).
Methods:
The expression of miRNA-218 was detected in the OS tumor tissues and OS cells. The Runx2 expression level was evaluated in Saos-2, 143B, U2OS, and MG-63. miRNA-218 overexpressed U2OS cells were achieved by transfection with miRNA-218 mimics. The role of miRNA-218 in inhibiting OS tumorigenesis was explored by CCK8, colony formation, cell wound scratch and Transwell assay. TargetScan and dual-luciferase reporter assay identified the interaction between miRNA-218 and Runx2. The inhibitive effect of miRNA-218 on OS through targeting Runx2 was also evaluated.
Results:
MiRNA-218 levels were remarkably down-regulated in OS tumor tissues and cell lines. The overexpression of miRNA-218 suppressed U2OS cell development and metastasis. The target interaction between miRNA-218 and Runx2 was validated, and their expression showed a negative correlation in U2OS cells. The suppressed U2OS cell development and metastasis were remarkably reversed by Runx2 overexpression.
Conclusion:
MiRNA-218 showed an inhibitive effect on the development and metastasis of osteosarcoma cell proliferation by targeting Runx2. Our findings may provide novel clues for OS treatment.
Insights
MicroRNA-218 (miRNA-218) suppresses osteosarcoma (OS) development and metastasis by targeting Runt-related transcription factor 2 (Runx2). This study reveals miRNA-218 as a potential therapeutic target for OS treatment.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- MicroRNA-218 (miRNA-218) deregulation is implicated in various cancers.
- Runt-related transcription factor 2 (Runx2) is a key regulator in bone development and cancer progression.
Purpose of the Study:
- To investigate the role of miRNA-218 in osteosarcoma (OS).
- To determine if miRNA-218 targets Runx2 in OS cells.
Main Methods:
- Quantified miRNA-218 and Runx2 expression in OS tissues and cell lines.
- Overexpressed miRNA-218 in U2OS cells and assessed its impact on proliferation and metastasis using CCK8, colony formation, wound scratch, and Transwell assays.
- Validated the interaction between miRNA-218 and Runx2 using TargetScan and dual-luciferase reporter assays.
Main Results:
- MiRNA-218 was significantly downregulated in OS tissues and cell lines.
- Overexpression of miRNA-218 inhibited OS cell proliferation and metastasis.
- A negative correlation between miRNA-218 and Runx2 expression was observed.
- Runx2 overexpression reversed the inhibitory effects of miRNA-218.
Conclusions:
- MiRNA-218 acts as a tumor suppressor in OS by targeting Runx2.
- This finding offers potential therapeutic strategies for osteosarcoma treatment.
Related Concept Videos
MicroRNAs
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Experimental RNAi
Abnormal Proliferation

